Telehealth During the COVID-19 Pandemic


The Centers for Medicare & Medicaid Services (“CMS”) and the Department of Health and Human Services (“HHS”) have enacted several measures to confront the public health emergency (“PHE”) caused by the coronavirus and the disease caused by it, COVID-19.  This alert addresses telehealth coverage and recent waivers issued by CMS and HHS that affect how telehealth services are delivered and paid for by Federal government payers. 

Medicare Coverage of Telehealth Services

Other Changes Due to Section 1135 Waivers 

The overwhelming purpose (and likely effect) of the Section 1135 waivers is to increase access to all reasonable and necessary medical services, even if those services are not related to the diagnosis and treatment COVID-19.  Although, there has been an expansion of where patients can receive telehealth services and from where providers can provide telehealth services, providers can expect challenges related to the facilitation of appropriate testing and how to accomplish testing for COVID-19 in patients who are evaluated via telehealth. Moreover, the Section 1135 Waivers only apply to Federal requirements and do not apply to State requirements. Providers should check state laws prior to beginning telehealth services.

Discretionary HIPAA Enforcement for Telemedicine Communications

The HHS Office for Civil Rights (“OCR”), the agency responsible for enforcing requirements under the Health Insurance Portability and Accountability Act (“HIPAA”), issued a notice that it will exercise enforcement discretion in connection with the provision of telehealth services. OCR stated that will not impose penalties for non-compliance with the HIPAA Rules against HIPAA-covered health care providers in connection with the “good faith provision of telehealth” during the PHE. Specifically, OCR’s announcement opened the door for health care providers to utilize communication platforms that may not typically meet all HIPAA standards and set forth the following parameters:

Although OCR further stated that the agency will not impose HIPAA penalties for lack of a business associate agreement (“BAA”) with such technology providers, the notice states that healthcare providers seeking additional privacy protections (making it seem optional) should choose vendors that comply with HIPAA (or at least purport to do so) and that will enter a BAA.  OCR specifically highlights certain vendors that agree to execute BAAs and hold themselves out as “HIPAA compliant,” including: Skype for Business, Updox, VSee, Zoom for Healthcare, Doxy.me and Google GSuite Hangouts Meet.  Even though the notice includes reference to a number of specific products, OCR expressly disclaims any endorsement or recommendation of the noted applications so it is likely safe to assume that use of one of the named products is not necessarily a safe harbor.  

While this leniency is an important measure to streamline the ability for providers to provide telehealth services during the current health crisis, there are still a number of factors health care providers should consider. For instance, OCR’s discretionary enforcement hinges on the “good faith provision of telehealth” which is an ambiguous threshold and is also directly tied to the present PHE. Therefore, it is unclear when this discretionary period will end or how OCR will walk back to its strict interpretation and scrutiny under the HIPAA Rules. As a result, health care providers and other covered entities should consider the following:

OCR’s notice of discretionary enforcement helps clear the path for providers to more quickly establish telehealth services during this difficult time.  However, this allowance is not a “free pass” and presumably has an expiration so health care entities should proceed with caution and make good faith efforts to partner with technology providers that offer reasonable compliance measures. 


Copyright © 2025 Womble Bond Dickinson (US) LLP All Rights Reserved.
National Law Review, Volume X, Number 80